DNA and RNA Extraction
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH OLAO
Contract Value
Not provided
Codes & Classification
Solicitation Number
PCA-NIA-02375
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Classification Code
R499
Additional Details
The National Institutes of Health (NIH), Office of Logistics and Acquisition Operations (OLAO), has issued a Special Notice (Procurement Identifier: PCA-NIA-02375) seeking specialized services for DNA and RNA extraction. This procurement is focused on the custom extraction of DNA from mouse whole blood (specifically white cell pellets), as well as the extraction of both DNA and RNA from a range of mouse organs, including lung, spleen, heart, kidney, brain, and liver. Additionally, the scope of work includes Agilent RNA quality control (QC) to ensure the integrity and reliability of the extracted nucleic acids.
The primary objective of this procurement is to maintain scientific continuity and data compatibility with previously generated datasets. The notice emphasizes that introducing alternative extraction chemistries, instrumentation, workflows, or QC thresholds would result in batch effects—systematic differences that could distort methylation signatures, gene expression profiles, and sequencing quality. Such discrepancies are not correctable through computational means and would render new data scientifically incompatible with existing datasets. This incompatibility would undermine the validity of combined analyses, jeopardizing both ongoing research efforts and the integrity of submitted manuscripts and continuation studies.
The procurement falls under NAICS Code 541714, which pertains to Research and Development in Biotechnology (except Nanobiotechnology), and is classified under Product Service Code R499 (Support—Professional: Other). There are no set-aside requirements for this opportunity, making it open to all qualified vendors. The place of performance is Bethesda, Maryland, United States.
The contracting entity is the National Institutes of Health, a federal agency under the Department of Health and Human Services. The primary point of contact for this notice is Clifford Lounsbury, who can be reached at [email protected] or by phone at 301-480-8827.
Interested parties should note that this is a Special Notice, not a solicitation for competitive proposals, and should review the opportunity details on SAM.gov (Opportunity ID: e718b7e348624613be7ec226f4bc09eb) for further information. The notice was posted on March 23, 2026, with responses due by March 30, 2026.
Contractors considering this opportunity should have demonstrated expertise in custom nucleic acid extraction from mouse tissues, experience with Agilent RNA QC, and the capability to replicate established workflows to ensure data compatibility. The ability to maintain strict consistency in extraction protocols and quality control is critical to the success of this project and the validity of the resulting scientific data.